Feature | February 01, 2021| By Dave Fornell, Editor

Most Popular Cardiology Technology Content in January 2021 

The most popular story in the month of January 2021 was on a small study that showed the new iPhone 12 can cause ICDs to stop functioning. COVID-19 content continues to rank among the top stories, including an article on the possible long-term cardiac consequences of COVID-19 infection in COVID long-haulers. 

February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of January 2021. This is based on the website’s record 726,770 pageviews for the month. 

1. iPhone 12 May Cause Implantable Cardioverter Defibrillators to Malfunction

2. FDA Says New COVID Virus Mutation May Cause False Negatives

3. Image Gallery Showing Impact of the COVID-19 Pandemic

4. The Long-term Cardiovascular Impact of COVID-19

5. Wireless Transcutaneous Energy Transfer (TET) System for Powering a LVAD is Successful

6. FDA Grants Break Through Device Designation for TricValve Transcatheter Bicaval Valves System

7. Interventional X-ray Equipment Markets Plummeted in 2020 Due to COVID

8. Cardiac Monitoring in the Time of COVID-19

9. Top 25 Stories in Cardiology in 2020

10. NIH Pauses Anticoagulant Trial For Critically Ill COVID-19 Patients

11. Medicare Expands Coverage for MitraClip in Heart Failure Patients

12. Who Qualifies for the COVID Vaccine Under CDC Guidelines

13. FDA Approved Second COVID-19 Vaccine From Moderna

14. FDA Clears Ultromics Echocardiography AI for Automated Identification of Coronary Artery Disease

15. TAVR Is Now Dominant Form of Aortic Valve Replacement in the United States

16. VIDEO: Rising Interest in Remote Monitoring of EP Devices in the COVID-19 Era

17. FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions

18. 8 Top Trend Takeaways in Medical Imaging From RSNA 2020

19. Edwards Sapien 3 TAVR Valve Receives Expanded Approval in Canada

20. FDA Clears Vericiguat to Treat Heart Failure Following Hospitalization

21. Canada Clears Medtronic Evolut TAVR for Both Bicuspid Valves and for All Low Risk Patients

22. Occlutech's Atrial Flow Regulator for Heart Failure Receives FDA Breakthrough Device Designation

23. 3-D Printing and Computer Aided Design Aids Structural Heart Interventions

24. First Patient Treated With Harpoon Transcatheter Mitral Valve Repair Device in U.S. Trial 

25. Long-term Outcomes After Coronary Bypass Show Worse Outcomes for Women

 

Related Popular Cardiology Technology Content: 

Most Popular Cardiology Technology Content in December 2020

Top 25 Stories in Cardiology in 2020

Top 25 Cardiology Videos on DAIC in 2020

Most Popular Cardiology Technology Content in November 2020

 

Related Content

#breakingnews The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. It is the first vaccine to be fully approved by the FDA, and experts say it is expected to open the door for further vaccine mandates.

Getty Images

News | Coronavirus (COVID-19) | August 23, 2021
August 23, 2021 — The U.S.
The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compromised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images #AHA #coronavirus #COVID19

The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compormised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images

News | Coronavirus (COVID-19) | August 18, 2021 | By Dave Fornell, Editor
August 18, 2021 — The U.S.
In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. ACC, HRS, ASNC, SCMR, SCCT, ASE, HFSA, STS, SCAI.

In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. 

Feature | Coronavirus (COVID-19) | July 30, 2021 | By Dave Fornell, Editor
July 30, 2021 — A coalition of 10 U.S.-based cardiovascular societies have issued a statement today in support of all
AHA president says COVID has a direct impact on the heart and preventive measures for heart disease largely went out the window during the pandemic

Getty Images

News | Coronavirus (COVID-19) | July 26, 2021
July 26, 2021 — Heart disease and stroke continue to kill more people in the U.S.
A new study with data from more than 10,000 COVID patients confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19.

A new study with data from more than 10,000 COVID patients confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19. Researchers believe statins, which attach to the ACE2 receptors, may block the virus from attaching to these same receptors. 

News | Coronavirus (COVID-19) | July 21, 2021
July 21, 2021 — In a new study from University of California San Diego School of Medicine, researchers have confirmed
New trial results from the international RAPID Trial show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. How to anticoagulate COVID patients. How to prevent thrombus in COVID patients.

New trial results from the international RAPID Trial show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. Getty Images
 

Feature | Coronavirus (COVID-19) | July 15, 2021
July 15, 2021 — COVID-19 is m
Diluting of a blood sample for real-time deformability cytometry testing. Researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen. Germany, were able to show for the first time COVID-19 significantly changes the size and stiffness of red and white blood cells, sometimes over months. From the study How a COVID-19 Infection Changes Blood Cells in the Long Run. Reasons for long COVID.

Diluting of a blood sample for real-time deformability cytometry testing. Researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen. Germany, were able to show for the first time COVID-19 significantly changes the size and stiffness of red and white blood cells, sometimes over months.

News | Coronavirus (COVID-19) | July 15, 2021
July 15, 2021 — Using real-time deformability cytometry, researchers at the...
Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.

Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.

News | Coronavirus (COVID-19) | June 28, 2021
June 28, 2021 - A recent analysis found that children and adolescents with multisystem inflammatory syndrome in child
The U.S. Food and Drug Administration (FDA) announced June 25 it has added a warning on the Moderna and Pfizer COVID-19 messenger RNA (mRNA) vaccine fact sheets to explain they may cause myocarditis in rare cases as a side effect. The agency said the side effect is very rare and patients generally recover quickly, but it can disportionally affect younger patients in their teens and early 20s. Getty Images

Getty Images

News | Coronavirus (COVID-19) | June 28, 2021 | Dave Fornell, Editor
June 28, 2021 — The U.S.
A small number of patients develop myocarditis after receiving the messenger RNA (mRNA) COVID-19 vaccines from Pfizer and Moderna. This recently raised concerns after numbers for this adverse reaction jumped in April and May, prompting review this week by the Centers for Disease Control and Prevention (CDC) Advisory Committee on the Immunization Practices (ACIP).

A small number of patients develop myocarditis after receiving the messenger RNA (mRNA) COVID-19 vaccines from Pfizer and Moderna. This recently raised concerns after numbers for this adverse reaction jumped in April and May, prompting review this week by the Centers for Disease Control and Prevention (CDC) Advisory Committee on the Immunization Practices (ACIP). Getty Images

Feature | Coronavirus (COVID-19) | June 24, 2021 | By Dave Fornell, Editor
A small number of patients develop inflammation leading to myocarditis after receiving the messenger RNA (mRNA)...